Director/PDMR Shareholding

RNS Number : 3377V

GlaxoSmithKline PLC

10 January 2012

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 10 January 2012 of an increase in their notional interests in Ordinary shares at a price of 1482 pence per Ordinary share and ADRs at a price of $46.13 per ADR following the notional re-investment of the dividend paid to shareholders on 5 January 2012.

	Ordinary shares	ADRs
Sir Andrew Witty	16,172.074
Dr M M Slaoui		4,349.247
Mr S Dingemans	2,302.416
Mr S M Bicknell	1,438.626
Mr J M Clarke	4,026.605
Mrs D P Connelly		2,559.470
Mr M Dunoyer	1,892.745
Mr E J Gray	3,038.769
Mr S A Hussain	3,973.136
Mr W C Louv		1,312.138
Dr D Pulman		1,966.647
Mr D S Redfern	1,853.468
Mr J R Stéphenne	2,328.843
Ms C Thomas	2,671.731
Mr P C Thomson	215.742
Mr D E Troy		2,596.086
Dr P J T Vallance	2,625.312
Ms E Walmsley	1,561.960
Mrs V A Whyte	215.742

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

10 January 2012

 

END

 

 

RDSDBLFFLFFXBBQ